HealGoFly - Medical Value Travel
HealGoFly
Oncology & Cancer Care Source: Asian Oncology Review 7 min read

Next-Generation Precision Oncology: CAR-T Cell Therapy and Targeted Immunotherapy

D
Dr. Vinod Raina, Chief of Oncology Published on November 08, 2026
4,314 Views
Next-Generation Precision Oncology: CAR-T Cell Therapy and Targeted Immunotherapy
How genomic sequencing, CAR-T cell immunotherapy, and proton beam therapy are turning refractory cancers into manageable chronic conditions.

The paradigm of cancer treatment has shifted decisively from blanket chemotherapy regimens to molecularly targeted therapies tailored to the exact genomic profile of each tumor.

The Promise of CAR-T Cell Therapy

Chimeric Antigen Receptor T-cell (CAR-T) therapy re-engineers a patient's own immune cells to seek out and eradicate cancerous cells. Previously available only in select Western research hospitals at costs exceeding $400,000, indigenous CAR-T innovations in India now offer this curative treatment at a fraction of the cost.

Proton Beam Therapy

Unlike standard X-ray photon radiation which irradiates healthy tissue on both sides of a tumor, protons deposit their maximum radiation dose directly at the tumor site (the Bragg Peak) and stop completely. This makes it the gold standard for pediatric tumors, brain malignancies, and prostate cancers.

Share this article: